Stocktoria
HAEMONETICS CORP HAE
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1979-10-17
HAEMONETICS CORP financials (annual, from 10-K)
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $1.3B | $1.4B | $1.3B | $1.2B | $993.2M |
| Gross profit | $787.6M | $749.0M | $691.5M | $615.1M | $505.5M |
| R&D expense | $59.8M | $62.7M | $54.4M | $50.1M | $46.8M |
| SG&A expense | $442.4M | $436.8M | $429.8M | $376.7M | $340.1M |
| Operating income | $156.7M | $221.8M | $164.9M | $156.0M | $80.8M |
| Income tax | $30.7M | $44.4M | $34.3M | $26.0M | $20.3M |
| Net income | $97.3M | $167.7M | $117.6M | $115.4M | $43.4M |
| EPS (diluted) | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 |
| Operating cash flow | $293.2M | $181.7M | $181.8M | $273.1M | $172.3M |
| Free cash flow | $260.4M | $142.4M | $143.6M | $81.7M | $75.8M |
| Cash & equivalents | $245.4M | $306.8M | $178.8M | $284.5M | $259.5M |
| Inventory | $306.4M | $365.1M | $317.2M | $259.4M | $293.0M |
| Total assets | $2.4B | $2.5B | $2.2B | $1.9B | $1.9B |
| Shareholders' equity | $796.3M | $820.8M | $960.0M | $818.0M | $749.4M |
Source: SEC EDGAR filings · CIK 0000313143 · as of 2026-03-28. Facts from filings plus Stocktoria's own computed scores — not investment advice.